Sector portfolio · VC firm · United States
Versant Ventures' Biotech portfolio
Versant Ventures has backed 67 Biotech startups in rounds we track, $6.6B between them, shown by the stage each has reached. The best-funded is Akero Therapeutics.
67startups backed
4stages
$6.6Braised between them
Series Bbiggest stage
Versant Ventures's whole portfolioVersant Ventures's profile
Series B
21
Akero Therapeutics
Passage Bio
Repare Therapeutics
Black Diamond Therapeutics
Abdera Therapeutics- OPOyster Point
Pandion
Therachon
Gritstone
GenSight Biologics
CardiAQ Valve Technologies
Ceterix Orthopaedics- GBGranite Bio
- ATAprea Therapeutics
Gate Bioscience
858 Therapeutics
Tentarix Biotherapeutics
Pipeline Therapeutics
Kate Therapeutics- GBGroove Biopharma
CELLutions Biosystems
Century Therapeutics
Monte Rosa Therapeutics
Intuity Medical
AcuFocus
Nuvaira
Veran Medical Technologies- CTChinook Therapeutics
- SSebacia
Contineum Therapeutics- IDImmune Design
SixPeaks Bio- AAnokion
- FLForSight Labs
- STSanReno Therapeutics
Tarveda Therapeutics- LPLaguna Pharmaceuticals
CODA Biotherapeutics
Launchpad TherapeuticsTempest Therapeutics
Series A
14
Funding by segment
- Series B$2.4B21
- Stage not reported$2.1B19
- Series A$820M14
- Series C and later$1.3B13
Where they are based
- United States52$5.0B
- Switzerland6$828M
- Canada4$504M
- France2$175M
- China1$40M
- Denmark1$84M
United States
Switzerland
Canada
France
China
DenmarkFounded
21Earlier
312
113
214
315
416
617
318
219
420
321
422
123
24
25
26
10 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M4
- $10M to $50M12
- $50M to $250M45
- $250M to $1B6
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
57 of 67 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States52
- Switzerland6
- Canada4
- France2
- China1
- Denmark1
Startups by country, 6 countries in all.
Segment by segment
Series B
21 startups · $2.4B raised
- Akero TherapeuticsAkero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.United States$502M
- Passage BioPassage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.United States$380M
- Repare TherapeuticsRepare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.Canada$252M
- Black Diamond TherapeuticsBlack Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.United States$160M
- Abdera TherapeuticsAbdera Therapeutics is a precision oncology company based in South San Francisco, California, with an additional office in Vancouver, Canada.Canada$142M
- OPOyster PointUnited States$115M
- PandionPandion was a technology-driven logistics startup founded in 2020, focused on providing an end-to-end shipping network for e-commeUnited States$100M
- TherachonTherachon is a global biotechnology company focused on developing medicines for rare, genetic diseasesFrance$95M
Stage not reported
19 startups · $2.1B raised
- Century TherapeuticsCentury Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.United States$385M
- Monte Rosa TherapeuticsMonte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.Switzerland$300M
- Intuity MedicalIntuity Medical develops blood glucose monitoring systems for diabetes management.United States$275M
- AcuFocusAcufocus is a medical device company that develops and markets KAMRA inlay for the treatment of near vision loss.United States$170M
- NuvairaNuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases.United States$115M
- Veran Medical TechnologiesVeran Medical Technologies is an image-guided medical device company that helps physicians diagnose disease and deliver therapies.United States$113M
- CTChinook TherapeuticsChinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.Canada$105M
- SSebaciaSebacia is a commercial-stage dermatology company that develops an alternative to the topical and systemic drugs for the treatment of acne.United States$102M
Series A
14 startups · $820M raised
Nexo TherapeuticsNexo Therapeutics is a biotechnology company dedicated to discovering and developing small-molecule therapies, particularly in oncUnited States$120M
Firefly BioFirefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.United States$94M
Nested TherapeuticsNested Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.United States$90M
Antag TherapeuticsAntag Therapeutics is a clinical-stage biopharmaceutical company based in Copenhagen, focused on developing innovative therapies fDenmark$84M
Dualitas TherapeuticsDualitas Therapeutics is a biotechnology company based in South San Francisco, CA, founded in 2023.United States$65M
Light Horse TherapeuticsLight Horse Therapeutics, Inc.United States$62M- GGothamUnited States$54M
AllRock BioAllRock Bio is a clinical-stage biotechnology company dedicated to developing therapies for cardiopulmonary and fibrotic diseases,United States$50M
Series C and later
13 startups · $1.3B raised
NouscomNouscom is a clinical-stage immuno-oncology company founded in 2015 and based in Basel, Switzerland, with operational facilities iSwitzerland$191M
Vividion TherapeuticsWe are bringing more disease-causing targets within the reach of small molecule therapeutics to transform care for patients with dUnited States$185M
Turnstone BiologicsTurnstone Biologics is a privately-held clinical stage biotech company.United States$133M
Jnana TherapeuticsJnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.United States$107M
Monteris MedicalMonteris Medical is a privately held company based in Minnetonka, Minnesota, focused on developing minimally invasive solutions foUnited States$104M
Integrated DiagnosticsIntegrated Diagnostics develops tools to help physicians diagnose complex diseases with a non-invasive blood test.United States$95M- STSynosia TherapeuticsSynosia Therapeutics develops and commercializes products for unmet medical needs in psychiatry and neurology.Switzerland$92M
Bright Peak TherapeuticsBright Peak Therapeutics is a private biotechnology company founded in 2017, with headquarters in Basel/Allschwil, Switzerland, anSwitzerland$90M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Versant Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosSector portfolioVersant Ventures' Healthtech portfolio10 startups · $343MPortfolio mapVersant Ventures portfolio map93 startups · $8.3BCo-investorsWho invests with Versant Ventures70 co-investorsSector portfolioTechstars' AI portfolio336 startups · $4.9BSector portfolioAlumni Ventures' AI portfolio302 startups · $36BSector portfolioAndreessen Horowitz's AI portfolio259 startups · $426B
Raising from investors like Versant Ventures?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.